Combinational blockade of MET and PD-L1 improves pancreatic cancer immunotherapeutic efficacy

Overview of attention for article published in Journal of Experimental & Clinical Cancer Research, September 2021

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age
Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter: 3 X users

Readers on

mendeley: 10 Mendeley

Summary X

So far, Altmetric has seen 3 X posts from 3 X users, with an upper bound of 3,542 followers.

MET was identified by Zhejiang University scientists as a pancreatic cancer-specific RTK, which is significantly associated with prognosis in both immune “hot” 🔥 and “cold” ❄️ pancreatic cancers. https://t.co/UK6wbYUyzR https://t.co/qdhpHSjCO4

07 Sep 2021

Reply Repost Favourite

Combinational blockade of MET and PD-L1 improves pancreatic cancer immunotherapeutic efficacy https://t.co/wauona5JTF

05 Sep 2021

Reply Repost Favourite

New article: Combinational blockade of MET and PD-L1 improves pancreatic cancer immunotherapeutic efficacy https://t.co/PdZMEuolOT #pancreaticcancer #oncology https://t.co/Kr2yHLlpVQ

04 Sep 2021

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.